ED
SGYP

Exane Derivatives’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Exane Derivatives’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$2 – 768
2018
Q3 		$2 Hold
1
– – ﹤0.01% 693
2018
Q2 		$2 Hold
1
– – ﹤0.01% 686
2018
Q1 		$2 Sell
1
-107,978
-100% -$228K ﹤0.01% 626
2017
Q4 		$241K Buy
107,979
+47,774
+79% +$119K 0.05% 225
2017
Q3 		$175K Buy
60,205
+52,722
+705% +$180K 0.04% 204
2017
Q2 		$33.3K Buy
+7,483
New +$30.9K 0.01% 342

Other funds holding SGYP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $3.42B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return